Warfarin works by inhibiting vitamin K–dependent clotting factors (II, VII, IX, X); your INR target (typically 2.0–3.0) reflects this inhibition balance. If you introduce 90–180 mcg K2 daily, your liver increases clotting factor carboxylation, pushing INR *downward*, potentially undercutting anticoagulation and raising venous thromboembolism (blood clot) risk by 20–30% within 2–4 weeks [9].
Your liver and warfarin are in a tug-of-war over vitamin K. Vitamin K2 gives your liver extra ammunition to win, counteracting the drug's effect. This is not a 'bad' interaction—it is a *pharmacodynamic* competition that requires your anticoagulation clinic to adjust warfarin dose and monitor INR every 2–4 weeks while stabilizing [9].
If you *need* bone protection while on warfarin, your doctor may prescribe vitamin K1 (phylloquinone) 500 mcg daily *with* warfarin at a stable, adjusted dose—a deliberate K1-warfarin balance. K2 MK-7 is harder to control because it accumulates over weeks; K1 is rapidly metabolized (1–2 hour half-life) and easier to titrate with warfarin dosing [9].
Try This Today
Before buying K2 supplements, call your anticoagulation clinic or cardiologist and say: 'I want to add vitamin K2 for bone health. Do I need INR checks, and would vitamin K1 be safer with my warfarin dose?' Let *them* decide if and how to introduce K2, then schedule INR draws every 2–4 weeks for 3 months to confirm stability.